Skip to content

RDNT

RadNet, Inc.

NASDAQ · USHealthcareMedical - Diagnostics & Research
$60.68-2.43%

Price as of Jul 20, 2026

RDNT growth

RadNet, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+14.7%
EBITDA
+43.2%
EBIT
+18.9%
EPS
+59.4%
Free cash flow
Operating cash flow
+35.8%

Forward estimates

Revenue
+10.3%
EBITDA
+34.0%
EPS
+677.9%

Three-year CAGR

Revenue
+12.6%
EBITDA
-3.0%
EBIT
+25.1%
Net income
EPS
Free cash flow
+39.0%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.